BioStock Intestor Meeting: Interview with Redwood Pharma

Stockholmbased Redwood Pharma participated in the BioStock Investor Meeting in September where CEO Martin Vidaeus presented the company’s work. Afterwards, BioStock had the chance to interview Vidaeus who told us more about Redwood Pharma’s projects RP501 and RP101, aimed at the treatment of dry eyes.

See the full interview at biostock.se:

https://www.biostock.se/en/2022/09/biostock-intestor-meeting-interview-with-redwood-pharma/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se